Skip to main content
SpringerLink
Log in

Clinical Features and Management of Severe Dermatological Reactions to Drugs

  • Review Article
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Cutaneous adverse drug reactions are a frequent occurrence and have been reported in more than 2% of hospitalised patients. Among the most commonly involved drugs are sulphonamides, penicillins, anticonvulsants and non-steroidal anti-inflammatory drugs.

Two groups of mechanisms are involved in the pathogenesis of drug reactions: immunological, with all 4 types of hypersensitivity reactions described; and non-immunological, accounting for at least 75% of all drug reactions.

Besides minor skin reactions like urticaria, maculopapular rash, fixed eruptions or erythema nodosum, which are generally self-limited, severe life-threatening manifestations also occur. Erythema multiforme is secondary to drugs in half the cases; the minor form is characterised by typical target and iris lesions and is usually benign. However, a much more severe condition, erythema multiforme major or Stevens-Johnson syndrome, is associated with mucosal, ocular and visceral involvement, and carries a mortality of 5 to 15% if untreated. Toxic epidermal necrolysis, which could represent an even more dramatic form of the same disease, is characterised by severe widespread erythema, blisters and loss of skin in sheets, with denudation of more than 10% of the body surface area. This entity is frequently due to drugs. Mortality is 25 to 70%, and 90% of the survivors will have sequelae.

Exfoliative dermatitis is an erythematous scaling disease often produced by drugs and carrying significant mortality. Photodermatitis may at times present with severe eczematous features.

For clinical and epidemiological reasons it is important to try to identify the culprit drug following an approach based on previous experience with the drug, timing of events, patient reaction to dechallenge, patient reaction to rechallenge (if feasible), alternative aetiological candidates, and drug concentration or evidence of overdose.

Management of severe skin reactions to drugs should require admission to a burn unit, where patients should be placed in warmed air-fluidised beds, receive excellent nursing care, analgesics and tranquillisers. Peeling necrotic epidermis should be removed and denuded dermis covered with biological grafts or synthetic dressings. Fluid balance must be adequately maintained; nutritional support and careful monitoring of early signs of skin infections is mandatory to ensure immediate antimicrobial treatment. Ocular care must be excellent to avoid serious sight-threatening sequelae. Steroids are presently not recommended. With these therapeutic modalities, morbidity and mortality can be markedly decreased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abraham GN, Petz LD, Fudenberg HH. Immunohematological cross-allergenicity between penicillin and cephalothin in humans. Clinical and Experimental Immunology 3: 343–357, 1968.

    PubMed  CAS  Google Scholar 

  • Abrahams I, McCarthy JT, Sanders SL. One hundred and one cases of exfoliative dermatitis. Archives of Dermatology 87: 96–101, 1963.

    PubMed  CAS  Google Scholar 

  • Ackerman AB, Penneys NS, Clark WH. Erythema multiforme exudativum: a distinctive pathological process. British Journal of Dermatology 84: 554–565, 1971.

    PubMed  CAS  Google Scholar 

  • Aderka D, Livni E, Sharon C, Pinkhas J. The migration inhibition factor test for identification of hypersensitivity reaction to drugs. Annals of Allergy 56: 341–344, 1986.

    PubMed  CAS  Google Scholar 

  • Adkinson Jr NF, Thompson W, Maddrey WC, Lichtenstein LM. Routine use of penicillin skin testing on an in patient service. New England Journal of Medicine 285: 22, 1971.

    PubMed  Google Scholar 

  • Adzick NS, Kim SH, Bondoc CC, Quinby WC, Remensnyder JP. Management of toxic epidermal necrolysis in a pediatric burn center. American Journal of Diseases of Children 139: 499–502, 1985.

    PubMed  CAS  Google Scholar 

  • Aihara M, Ikezawa Z. Evaluation of skin test reactions in patients with delayed type rash induced by penicillins and cephalosporins. Journal of Dermatology 14: 440–448, 1987.

    PubMed  CAS  Google Scholar 

  • Amon RB, Dimond RL. Toxic epidermal necrolysis: rapid differentiation between staphylococcal- and drug-induced disease. Archives of Dermatology 111: 1433–1437, 1975.

    PubMed  CAS  Google Scholar 

  • Anhalt G, Snelling CFT. Toxic epidermal necrolysis. Plastic and Reconstructive Surgery 61: 905–910, 1978.

    PubMed  CAS  Google Scholar 

  • Araujo OE, Flowers FP. Stevens-Johnson syndrome. Journal of Emergency Medicine 2: 129–135, 1984.

    PubMed  CAS  Google Scholar 

  • Arndt KA, Jick H. Rates of cutaneous reactions to drugs. Journal of the American Medical Association 235: 918–923, 1976.

    PubMed  CAS  Google Scholar 

  • Arstikaitis MJ. Ocular aftermaths of Stevens-Johnson syndrome. Archives of Ophthalmology 90: 376, 1973.

    PubMed  CAS  Google Scholar 

  • Ashby DW, Lazar T. Erythema multiforme exudativum major (Stevens-Johnson syndrome). Lancet 1: 1091–1095, 1951.

    PubMed  CAS  Google Scholar 

  • Askenase PW. Role of basophils, mast cells, and vasoamines in hypersensitivity reactions with a delayed time course. Progress in Allergy 23: 199–320, 1977.

    PubMed  CAS  Google Scholar 

  • Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France. Thérapie 40: 111–118, 1985.

    PubMed  CAS  Google Scholar 

  • Benichou C, Brini A, Abensour M, Grosshans E. Lesions oculopalpebrales dans les erythèmes polymorphes graves: prevention du symblepharon. Bulletin des Sociétés d’Ophthalmologie de France 88: 391–396, 1988.

    CAS  Google Scholar 

  • Bianchine JR, Macaraeg Jr PV, Lasagna L, Azarnoff DL, Brunk SF, et al. Drugs as etiologic factors in the Stevens-Johnson syndrome. American Journal of Medicine 44: 390–405, 1968.

    PubMed  CAS  Google Scholar 

  • Björnberg A. Fifteen cases of toxic epidermal necrolysis (Lyell). Acta Dermato-Venereologica 53: 149–152, 1973.

    PubMed  Google Scholar 

  • Burleson R, Eiseman B. Effect of skin dressings and topical antibiotics on healing of partial thickness skin wounds in rats. Surgical Gynecology and Obstetrics 136: 958, 1973.

    CAS  Google Scholar 

  • Cazzola G, Nicolussi M, Carraro F, Cavalieri S, Graziani MS. High-dose i.v. 7S immunoglobulin treatment in Stevens-Johnson syndrome. Helvetica Paediatrica Acta 41: 87–88, 1986.

    PubMed  CAS  Google Scholar 

  • Centers for Disease Control. Health information for international travel 1988. US Department of Health and Human Services Publication No. (CDC) 88–8280, p. 102, Public Health Service, Atlanta, 1988

    Google Scholar 

  • Chan HL. Observations on drug-induced toxic epidermal necrolysis in Singapore. Journal of the American Academy of Dermatology 10: 973–978, 1984.

    PubMed  CAS  Google Scholar 

  • Charlesworth EN. Phenytoin induced pseudolymphoma syndrome. Archives of Dermatology 113: 477, 1977.

    PubMed  CAS  Google Scholar 

  • Chong BH, Pitney WR, Castaldi PA. Heparin induced thrombocytopenia: association of thrombotic complications with heparin dependent IgG antibody that induced thromboxane synthesis and platelet aggregation. Lancet 2: 1246–1249, 1982.

    PubMed  CAS  Google Scholar 

  • Clouse LH, Comp PC. The regulation of hemostasis: the protein C system. New England Journal of Medicine 314: 1298–1305, 1986.

    PubMed  CAS  Google Scholar 

  • Comaish JK, Kerr DN. Erythema multiforme and nephritis. British Medical Journal 2: 84, 1961.

    PubMed  CAS  Google Scholar 

  • Coombes RRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In Gell (Ed.) Clinical aspects of Immunology, pp. 575–596, Oxford Ed., Oxford, 1968

    Google Scholar 

  • Crosby SS, Murray KM, Marvin JA, Heimbach DM, Tartaglione TA. Management of Stevens-Johnson syndrome. Clinical Pharmacology 5: 682–689, 1986.

    CAS  Google Scholar 

  • Davidson BL, Gilliam JN, Lipsky PE. Cimetidine-associated exacerbations of cutaneous lupus erythematosus. Archives of Internal Medicine 142: 166–167, 1982.

    PubMed  CAS  Google Scholar 

  • Davidson BL, Hunt JL. Human cadaver homograft in toxic epidermal necrolysis. Journal of Burn Care and Rehabilitation 2: 94–96, 1981.

    Google Scholar 

  • Davies P, Ryan DW. Stevens-Johnson syndrome managed in the clinitron bed. Intensive Care Medicine 9: 87–89, 1983.

    PubMed  CAS  Google Scholar 

  • DeFoe Jr CP. Erythema multiforme bullosum caused by 9-bromofluorene. Archives of Dermatology 94: 545–551, 1966.

    Google Scholar 

  • Demling RH. Burns. New England Journal of Medicine 313: 1389–1398, 1985.

    PubMed  CAS  Google Scholar 

  • Demling RH, Ellerbe S, Lowe NJ. Burn unit management of toxic epidermal necrolysis. Archives of Surgery 113: 758–759, 1978.

    PubMed  CAS  Google Scholar 

  • DeSwarte RD. Drug allergy. In Patterson (Ed.) Allergic diseases: diagnosis and management, pp. 505–661, JB Lippincott, Philadelphia, 1985

    Google Scholar 

  • Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization. New England Journal of Medicine 317: 1376–1382, 1987.

    PubMed  CAS  Google Scholar 

  • Dunagin WG, Millikan LE. Drug eruptions. Medical Clinics of North America 64: 983–1003, 1980.

    PubMed  CAS  Google Scholar 

  • Eisen HN. Hypersensitivity to simple chemicals. In Sherwood (Ed.) Cellular and humoral aspects of the hypersensitive states, pp. 89–122, Hoeber-Harper, New York, 1959

    Google Scholar 

  • Elias PM, Fritsch PO. Erythema multiforme. In Fitzpatrick et al. (Eds) Dermatology in general medicine, pp. 555–563, McGraw-Hill Book Company, New York-St Louis, 1987

    Google Scholar 

  • Elsas T, Halan H. Fansidar indusert makulopati og dermatitis exfoliativa. Tidsskrift for den Norske Laegeforening 107: 1231–1232, 1987.

    PubMed  CAS  Google Scholar 

  • Farah FS, Kern M, Eisen HN. Specific inhibition of wheal-and-erythema responses with univalent haptens and univalent antibody fragments. Journal of Experimental Medicine 112: 1211–1226, 1960.

    PubMed  CAS  Google Scholar 

  • Ferguson J, Johnson BE. Retinoid associated phototoxicity and photosensitivity. Pharmacology and Therapeutics 40: 123–135, 1989.

    PubMed  CAS  Google Scholar 

  • Finland M, Jolliffe LS, Parker Jr F. Pneumonia and erythema multiforme exudativum: report of 4 cases and 3 autopsies. American Journal of Medicine 4: 473–492, 1948.

    PubMed  CAS  Google Scholar 

  • Finlay AY, Richards J, Holt PJA. Intensive therapy unit management of toxic epidermal necrolysis: practical aspects. Clinical and Experimental Dermatology 7: 55–60, 1982.

    PubMed  CAS  Google Scholar 

  • Fischl MA, Dickinson GM. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome. Annals of Internal Medicine 105: 629, 1986.

    PubMed  CAS  Google Scholar 

  • Freedberg IM, Baden HP. Exfoliative dermatitis. In Fitzpatrick et al. (Eds) Dermatology in general medicine, pp. 502–505, McGraw-Hill Book Company, New York-St. Louis, 1987

    Google Scholar 

  • Friedman SJ, Perry HO. Erythema multiforme associated with contact dermatitis. Contact Dermatitis 12: 21–23, 1985.

    PubMed  CAS  Google Scholar 

  • Fritsch PO, Elias PM. Toxic epidermal necrolysis. In Fitzpatrick et al. (Eds) Dermatology in general medicine, McGaw-Hill Book Company, New York-St. Louis, 1987

    Google Scholar 

  • Garabiol B, Touraine R. Syndrome de Lyell de l’adulte: éléments de prognostic et déductions thérapeutiques: étude de 27 cas. Annales de Médecine Interne 127: 670–672, 1976.

    PubMed  CAS  Google Scholar 

  • Gerard A. Lyell’s syndrome: treatment by plasma exchange. Plasma Therapy and Transfusion Technology 5: 259–260, 1984.

    Google Scholar 

  • Ginsburg CM. Stevens-Johnson syndrome in children. Pediatric Infectious Diseases 1: 155–158, 1982.

    CAS  Google Scholar 

  • Girard JP, Cattin S, Cuevas M. Immunologic mechanisms and diagnostic test in allergie drug reactions. Annals of Clinical Research 8: 74–84, 1976.

    PubMed  CAS  Google Scholar 

  • Goldstein SM, Wintroub BW, Elias PM, Wuepper KD. Toxic epidermal necrolysis: unmudding the waters. Archives of Dermatology 123: 1153–1156, 1987.

    PubMed  CAS  Google Scholar 

  • Griffith RD, Miller OF. Erythema multiforme following diphtheria and tetanus toxoid vaccination. Journal of the American Academy of Dermatology 19: 758–759, 1988.

    PubMed  CAS  Google Scholar 

  • Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell’s syndrome). Archives of Dermatology 123: 1166–1170, 1987.

    PubMed  CAS  Google Scholar 

  • Halebian PH, Corder V, Herndon D, et al. A burn center experience with toxic epidermal necrolysis. Journal of Burn Care and Rehabilitation 4: 176–183, 1983.

    Google Scholar 

  • Halebian PH, Madden MR, Finklestein JL, Corder VJ, Shires GT. Improved burn center survival of patients with toxic epidermal necrolysis without corticosteroids. Annals of Surgery 204: 503–512, 1986.

    PubMed  CAS  Google Scholar 

  • Heimbach DM, Engrav LH, Marvin JA, Harnar TJ, Grube BJ. Toxic epidermal necrolysis: a step forward in treatment. Journal of the American Medical Association 257: 2172–2175, 1987.

    Google Scholar 

  • Holst R, Kirby J. Magnusson B. Sensitization to tropical woods firing erythema multiforme-like eruptions. Contact Dermatitis 2: 295–296, 1976.

    PubMed  CAS  Google Scholar 

  • Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria and causes. Journal of the American Academy of Dermatology 8: 763–775, 1983.

    PubMed  CAS  Google Scholar 

  • Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AG, et al. An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. Journal of the American Medical Association 242: 633–638, 1979.

    PubMed  CAS  Google Scholar 

  • Ikeda N, Umetsu K, Suzuki T. A fatal case of sulindac-induced Lyell syndrome (toxic epidermal necrolysis). Zeitschrift für Rechtsmedizin 98: 141–146, 1987.

    CAS  Google Scholar 

  • Jackson AM, Polock AV. Skin necrosis after heparin injection. British Medical Journal 282: 1088–1089, 1981.

    Google Scholar 

  • Jones JK. Adverse reactions in community health setting. Family and Community Health 5: 58–67, 1982.

    PubMed  CAS  Google Scholar 

  • Jorup-Rönström C, Keisu M, Wiholm B-E. Could Swedish ‘yellow cards’ be substituted by E-coded summaries? Drug Safety 5: 72–77, 1990.

    PubMed  Google Scholar 

  • Juhlin L, Wide L. IgE antibodies and penicillin allergy. In Dash & Jones (Eds) Mechanisms in drug allergy, Glaxo symposium series, pp. 139–147, Williams & Wilkins Company, Baltimore, 1972

    Google Scholar 

  • Kalhan SB, Ditto SR. Anesthetic management of a child with Stevens-Johnson syndrome. Cleveland Clinical Journal of Medicine 55: 467–469, 1988.

    CAS  Google Scholar 

  • Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Archives of Dermatology 121: 1548–1549, 1985.

    PubMed  CAS  Google Scholar 

  • Kaplan AP. Drug-induced skin diseasea. Journal of Allergy and Clinical Immunology 74 (4 pt 2): 573–579, 1984

    PubMed  CAS  Google Scholar 

  • Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clinical and Pharmacological Therapeutics 21: 247–254, 1977.

    CAS  Google Scholar 

  • Kazmierowski JA, Wuepper KA. Erythema multiforme: immune complex vasculitis of the superficial cutaneous vasculature. Journal of Investigative Dermatology 71: 366–369, 1978.

    PubMed  CAS  Google Scholar 

  • Kim PS, Goldfarb IW, Gaisford JC, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: a pathophysiologic review with recommendations for a treatment protocoal. Journal of Burn Care & Rehabilitation 4: 91–100, 1983.

    Google Scholar 

  • Kint A, Geerts ML, de Weert J. Le syndrome de Lyell. Dermatologica 163: 433–454, 1981.

    PubMed  CAS  Google Scholar 

  • Kirby JD, Darley CR. Erythema multiforme associated with a contact dermatitis to terpenes. Contact Dermatitis 4: 278, 1978.

    Google Scholar 

  • Kniker WT, Cochrane CG. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. Journal of Experimental Medicine 127: 119–136, 1968.

    PubMed  CAS  Google Scholar 

  • Kovacs JA, Masur H. Pneumocystis carinii pneumonia: therapy and prophylaxis. Journal of Infectious Diseases 158: 254–259, 1988.

    PubMed  CAS  Google Scholar 

  • Kramer MS, Leventhal JM, Hutchinson TA, Feinstein A. An algorithm for the operational assessment of adverse drug reaction. I. Background, description, and instructions for use. Journal of the American Medical Association 242: 623, 1979.

    PubMed  CAS  Google Scholar 

  • Lee SL, Chase PH. Drug-induced systemic lupus erythematosus: a critical review. Seminars in Arthritis and Rheumatism 5: 83–103, 1975.

    PubMed  CAS  Google Scholar 

  • Lepage V, Douay C, Mallet C, BInet O, Lemarchand F, et al. Erythema multiforme is associated to HLA-Aw33 and DRw53. Tissue Antigens 32: 170–175, 1988.

    PubMed  CAS  Google Scholar 

  • Levine BB. Immunochemical mechanisms of drug allergy. Annual Review of Medicine 17: 23–38, 1966.

    PubMed  CAS  Google Scholar 

  • Levine BB. Immunological tests for hypersensitivity reactions of drugs. In Rose & Friedman (Eds) Manual of Clinical Immunology, p. 637, American Society for Microbiology, Washington, 1976

    Google Scholar 

  • Ljunggren B, Bjellerup M. Systemic drug photosensitivity. Photodermatology 3: 26–35, 1986.

    PubMed  CAS  Google Scholar 

  • Lozada F. Levamisole in the treatment of erythema multiforme: a double blind trial in fourteen patients. Oral Surgery, Oral Medicine and Oral Pathology 53: 28–31, 1982.

    CAS  Google Scholar 

  • Lozada-Nur F, Gorsky M, Silverman S. Oral erythema multiforme: clinical observations and treatment of 95 patients. Oral Surgery, Oral Medicine and Oral Pathology 67: 36–40, 1989.

    CAS  Google Scholar 

  • Luger TA, Oppenheim JJ. Characteristics of interleukin-1 and epidermal cell-derived thymocyte activating factor. In Weissman (Ed.) Advances in inflammation research, pp. 1–25, Raven Press, New York, 1983

    Google Scholar 

  • Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. British Journal of Dermatology 68: 355, 1956.

    PubMed  CAS  Google Scholar 

  • Lyell A. A review of toxic epidermal necrolysis. British Journal of Dermatology 79: 662–671, 1967.

    PubMed  CAS  Google Scholar 

  • Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. British Journal of Dermatology 100: 69–86, 1979.

    PubMed  CAS  Google Scholar 

  • Marsden RA, Ryan TJ, Vanhegan RI, Walshe M, Hil H, et al. Pemphigus foliaceus induced by penicillamine. British Medical Journal 2: 1423–1424, 1976.

    PubMed  CAS  Google Scholar 

  • Marvin JA, Heimbach DM, Engrav H, Harnar TJ. Improved treatment of the Stevens-Johnson syndrome. Archives of Surgery 119: 601–605, 1984.

    PubMed  CAS  Google Scholar 

  • McDonald K, Johnson B, Prasad JK, Thompson PD. Rehabilitative considerations for patients with severe Stevens-Johnson syndrome or toxic epidermal necrolysis. Journal of Burn Care and Rehabilitation 10: 167–171, 1989.

    PubMed  CAS  Google Scholar 

  • Melmon KL. Preventable drug-reactions — causes and cures. New England Journal of Medicine 284: 1361–1368, 1971.

    PubMed  CAS  Google Scholar 

  • Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. American Journal of Hospital Pharmacy 43: 1709–1714, 1986a.

    PubMed  CAS  Google Scholar 

  • Michel DJ, Knodel LC. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital. American Journal of Hospital Pharmacy 43: 2202–2205, 1986b.

    PubMed  CAS  Google Scholar 

  • Miller KD, Lobei HO, Satriale RF, Kuritsky JN, Stern R, et al. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. American Journal of Tropical Medicine and Hygiene 35: 451–458, 1986.

    PubMed  CAS  Google Scholar 

  • Moore N, Paux G, Begaud B, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 2: 1056–1058, 1985.

    PubMed  CAS  Google Scholar 

  • Morison WL, McAuliffe DJ, Parrish JA, Bloch KJ. In vitro assay for phototoxic chemicals. Journal of Investigative Dermatology 78: 460–463, 1982.

    PubMed  CAS  Google Scholar 

  • Nalbandian RM, Mader IJ, Barret JL, Pearce JF, Rupp EC. Petechiae, ecchymoses, and necrosis of skin induced by coumarin congeners. Journal of the American Medical Association 192: 603–608, 1965.

    PubMed  CAS  Google Scholar 

  • Naranjo CA, Busto A, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 30: 239–245, 1981.

    PubMed  CAS  Google Scholar 

  • Navin TR, Miller KD, Satriale RF, Obel HO. Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for pneumocystis carinii infections in AIDS. Lancet 1: 1332, 1985.

    PubMed  CAS  Google Scholar 

  • Nethercott JR, Choi BCK. Erythema multiforme (Stevens-Johnson syndrome) — chart review of 123 hospitalized patients. Dermatologica 171: 383–396, 1985.

    PubMed  CAS  Google Scholar 

  • Nicolis GD, Helwig EB. Exfoliative dermatitis: a clinicopathol-ogic study of 135 cases. Archives of Dermatology 108: 788–797, 1973.

    PubMed  CAS  Google Scholar 

  • Orfanos CE, Schaumburg-Lever G, Lever WF. Dermal and epidermal types of erythema multiforme: a histopathologic study of 24 cases. Archives of Dermatology 109: 682–688, 1974.

    PubMed  CAS  Google Scholar 

  • Parker CW. Allergic drug response mechanisms and unsolved problems. Critical Reviews in Toxicology 1: 261–277, 1972.

    Google Scholar 

  • Parker CW. Drug allergy. New England Journal of Medicine 292: 511, 732, 957, 1975.

    PubMed  CAS  Google Scholar 

  • Patterson JW, Parsons JM, Blaylock WK, Mills AS. Eosinophils in skin lesions of erythema multiforme. Archives of Pathology and Laboratory Medicine 113: 36–39, 1989.

    PubMed  CAS  Google Scholar 

  • Payne FE, Giesecke TF. Multiple system reaction to trimethoprim-sulfamethoxazole. Southern Medical Journal 80: 275–276, 1987.

    PubMed  Google Scholar 

  • Peltier GL, Poppe SR, Twomey JA. Controlled air suspension: an advantage in burn care. Journal of Burn Care and Rehabilitation 8: 558–560, 1987.

    PubMed  CAS  Google Scholar 

  • Penneys NS. Gold dermatitis, a clinical and histopathological study. Archives of Dermatology 109: 372, 1974.

    PubMed  CAS  Google Scholar 

  • Perry Jr HM, Sakamoto A, Tan EM. Relationship of actylating enzyme to hydralazine toxicity. Journal of Laboratory and Clinical Medicine 70: 1020–1021, 1967.

    Google Scholar 

  • Petz LD, Füdenberg H. Coombs-positive hemolytic anemia caused by penicillin administration. New England Journal of Medicine 274: 171–178, 1966.

    PubMed  CAS  Google Scholar 

  • Prasad JK, Feller I, Thompson PD. Use of amnion for the treatment of Stevens-Johnson syndrome. Journal of Trauma 26: 945–946, 1986.

    PubMed  CAS  Google Scholar 

  • Rassmussen JE. Erythema multiforme in children: response to treatment with systemic corticosteroids. British Journal of Dermatology 95: 181–186, 1976.

    Google Scholar 

  • Rassmussen JE. Update on the Stevens-Johnson syndrome. Cleveland Clinic Journal of Medicine 55: 412–414, 1988.

    Google Scholar 

  • Raviglione MC, Dinan WA, Pablos-Mendez A, Palagiano A, Sabatini MT. Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person. Archives of Internal Medicine 148: 2683–2685, 1988.

    PubMed  CAS  Google Scholar 

  • Ressler C, Mendelson LM. Skin test for diagnosis of penicillin allergy — current status. Annals of Allergy 59: 167–170, 1987.

    PubMed  CAS  Google Scholar 

  • Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Archives of Dermatology 123: 1160–1165, 1987a.

    PubMed  CAS  Google Scholar 

  • Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R. Treatment of toxic epidermal necrolysis: Crétei’s experience. Archives of Dermatology 123: 1156–1158, 1987b.

    PubMed  CAS  Google Scholar 

  • Rocklin RE, David JR. Detection in vitro of cellular hypersensitivity to drugs. Journal of Allergy and Clinical Immunology 48: 276, 1971.

    PubMed  CAS  Google Scholar 

  • Roed-Petersen J. Erythema multiforme as an expression of contact dermatitis. Contact Dermatitis 1: 270–271, 1975.

    PubMed  CAS  Google Scholar 

  • Romeu J, Clotet B, Tural C, Carles J, Foz M. Therapeutic challenge for Isospora belli enteritis in an AIDS patient who developed Lyell syndrome after co-trimoxazole therapy. American Journal of Gastroenterology 84: 207–208, 1989.

    PubMed  CAS  Google Scholar 

  • Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, et al. Genetic susceptibility to toxic epidermal necrolysis. Archives of Dermatology 123: 1171–1173, 1987.

    PubMed  CAS  Google Scholar 

  • Roujeau JC, Moritz S, Guillaume JC, Bombai C, Revuz J, et al. Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis. Archives of Dermatology Research 277: 24–27, 1985.

    CAS  Google Scholar 

  • Ruiz-Maldonado R. Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases. Journal of the American Academy of Dermatology 13: 623–635, 1985.

    PubMed  CAS  Google Scholar 

  • Savel H, Madison JF, Meeker CI. Cutaneous eruptions and in vitro lymphocyte hypersensitivity associated with oral contraceptives and mestranol. Archives of Dermatology 101: 187–190, 1970.

    PubMed  CAS  Google Scholar 

  • Schmidt LG, Dirschdl P, Grohmann R, Scherer J, Wunderlich O, et al. Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithm and an empirical approach. European Journal of Clinical Pharmacology 30: 199–204, 1986.

    PubMed  CAS  Google Scholar 

  • Shapiro S, Slone D, Siskind V, Lewis GP, Herschel JICK. Drug rash with ampicillin and other penicillins. Lancet 2: 969–972, 1969.

    PubMed  CAS  Google Scholar 

  • Shum S. Stevens-Johnson syndrome: a pediatric experience. Louisiana State Journal of Medicine 128: 331–333, 1976.

    CAS  Google Scholar 

  • Simons HW. Acute life threatening dermatologic disorders. Medical Clinics of North America 65: 227–243, 1981.

    PubMed  CAS  Google Scholar 

  • Soter NA, Fitzpatrick TB. Cutaneous changes in disorders of altered reactivity: eczematous dermatitis. In Fitzpatrick et al. (Eds). Dermatology in general medicine, pp. 1367–1373, McGraw-Hill Book Company, New York-St. Louis, 1987

    Google Scholar 

  • Stein MR, Thompson CK, Sawicki JE, et al. Esophageal stricture complicating Stevens-Johnson syndrome. American Journal of Gastroenterology 62: 435–439, 1974.

    PubMed  CAS  Google Scholar 

  • Stephens MDB. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug Reactions and Acute Poisoning Reviews 6: 1–35, 1987.

    PubMed  CAS  Google Scholar 

  • Stevens AM, Johnson FC. A New eruptive fever associated with stomatitis and ophthalmia. American Journal of Diseases of Children 24: 526–533, 1922.

    Google Scholar 

  • Straus DA. Generalized bullous eruption following testing for sulfonamide-hypersensitivity. New England Journal of Medicine 239: 956–958, 1948.

    PubMed  CAS  Google Scholar 

  • Szczeklick A, Gryglewski RJ, Czerniawska-Mysik G, Zmuda A. Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. Journal of Allergy and Clinical Immunology 58: 10–18, 1976.

    Google Scholar 

  • Ting HC, Adam BA. Erythema multiforme — response to corticosteroid. Dermatologica 169: 175–178, 1984.

    PubMed  CAS  Google Scholar 

  • Ting HC, Adam BA. Stevens-Johnson syndrome: a review of 34 cases. International Journal of Dermatology 24: 587–591, 1985.

    PubMed  CAS  Google Scholar 

  • Tonnesen MG, Soter NA. Erythema multiforme. Journal of the American Academy of Dermatology 1: 357–364, 1979.

    PubMed  CAS  Google Scholar 

  • Tosti A, Bardazzi F, Valeri F, Toni F. Erythema multiforme with contact dermatitis to hair dyes. Contact Dermatitis 17: 321–322, 1987.

    PubMed  CAS  Google Scholar 

  • Tseng SCG. Topical tretinoin treatment for severe dry-eye disorders. Journal of the American Academy of Dermatology 15: 860–866, 1986.

    PubMed  CAS  Google Scholar 

  • Von Hebra F. On diseases of the skin including the exanthemata, Vol. 1, pp. 285–289, New Sydenham Society, London, 1866–1880

    Google Scholar 

  • Westly ED, Wechsler HL. Toxic epidermal necrolysis: granulocytic leukopenia as a prognostic indicator. Archives of Dermatology 120: 721–726, 1984.

    PubMed  CAS  Google Scholar 

  • Wide L, Bennich H, Johansson SGO. Diagnosis of allergy by an in vitro test for allergen antibodies. Lancet 2: 1105–1107, 1967.

    PubMed  CAS  Google Scholar 

  • Wintroub BU, Stern RS, Arndt KA. Cutaneous reactions to drugs. In Fitzpatrick et al. (Eds) Dermatology in general medicine, pp. 1353–1366, McGraw-Hill Book Company, New York-St. Louis, 1987

    Google Scholar 

  • Wong KS, Wong SN, Tham SN, Giam YC. Generalized exfoliative dermatitis — a clinical study of 108 patients. Annals of the Academy of Medicine 17: 522–525, 1988.

    Google Scholar 

  • Yaffee HS, Dressler DP. Topical application of mefenide acetate: its association with erythema multiforme. Archives of Dermatology 100: 277–281, 1969.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Cabrini Medical Center, 227 East 19th Street, New York, NY, 10003, USA

    Mario C. Raviglione, Ariel Pablos-Mendez & Ruggero Battan

Authors
  1. Mario C. Raviglione
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ariel Pablos-Mendez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ruggero Battan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raviglione, M.C., Pablos-Mendez, A. & Battan, R. Clinical Features and Management of Severe Dermatological Reactions to Drugs. Drug-Safety 5, 39–64 (1990). https://doi.org/10.2165/00002018-199005010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199005010-00005

Keywords

Search

Navigation